78 related articles for article (PubMed ID: 3502315)
1. Binding of organic acids to surface receptors of lymphocytes as an immunosuppressive mechanism in uremia.
Sanaka T; Hayasaka Y; Kawashima Y; Takuma T; Sugino N; Ota K; Gulyassy PF
Adv Exp Med Biol; 1987; 223():165-9. PubMed ID: 3502315
[No Abstract] [Full Text] [Related]
2. The immunosuppressive fraction isolated from uremic ultrafiltrates: attempted characterization of the mechanism of action.
Navarro J; Grossetête MC; Touraine JL; Traeger J
Adv Exp Med Biol; 1987; 223():157-60. PubMed ID: 3128939
[No Abstract] [Full Text] [Related]
3. Lymphocytes of persons with the acquired immunodeficiency syndrome and related conditions express reactivity with the monoclonal antibody 4D12 reflective of in vivo lymphocyte activation.
Lederman MM; Carey JT; Schacter B; Aucott J; Ellner JJ
Hum Immunol; 1987 Dec; 20(4):279-91. PubMed ID: 3125134
[TBL] [Abstract][Full Text] [Related]
4. Modulation of CD7 is associated with inhibition of T cell proliferation in response to tetanus toxoid and phytohemagglutinin.
Lazarovits AI; Karsh J
Transplant Proc; 1989 Apr; 21(2):3325-7. PubMed ID: 2469235
[No Abstract] [Full Text] [Related]
5. Possible T4-HLA class II interaction as an essential event in antigen-specific helper T lymphocyte-dependent B cell activation.
Fischer A; Sterkers G; Charron D; Durandy A
Eur J Immunol; 1986 Sep; 16(9):1111-6. PubMed ID: 2944748
[TBL] [Abstract][Full Text] [Related]
6. Reactivity of eleven anti-human leucocyte monoclonal antibodies with lymphocytes from several domestic animals.
Aasted B; Blixenkrone-Møller M; Larsen EB; Bielefeldt Ohmann H; Simesen RB; Uttenthal A
Vet Immunol Immunopathol; 1988 Jul; 19(1):31-8. PubMed ID: 2972111
[TBL] [Abstract][Full Text] [Related]
7. Immunosuppressive effect of soluble E receptors in uremic serum.
Musatti CC; Soares VA; Santos LM; De Lima JJ; Mendes NF
Clin Immunol Immunopathol; 1979 Dec; 14(4):403-10. PubMed ID: 159794
[No Abstract] [Full Text] [Related]
8. Role of Ti/CD3, Thy-1, and Ly-6 in cytolytic T-cell activation analyzed with Ti loss variants.
Langlet C; Guimezanes A; Kaldy P; Boyer C; Buferne M; Poenie M; Tsien R; Leo O; Bluestone J; Leserman L
Ann N Y Acad Sci; 1988; 532():33-43. PubMed ID: 2902820
[No Abstract] [Full Text] [Related]
9. T cell alloresponses against HLA-DQ and -DR products involve multiple epitopes on the CD4 molecule. Distinct mechanisms contribute to the inhibition of HLA class II-dependent and -independent T cell responses by antibodies to CD4.
Merkenschlager M; Altmann DM; Ikeda H
J Immunol; 1990 Nov; 145(10):3181-7. PubMed ID: 1699999
[TBL] [Abstract][Full Text] [Related]
10. A monoclonal anti-tac antibody may interfere with receptor binding of interleukin 2.
Taniguchi N; Miyawaki T; Yachie A
Lymphokine Res; 1982; 1(4):107-12. PubMed ID: 6097775
[No Abstract] [Full Text] [Related]
11. Combined immunosuppressive effect of FK 506 and other immunosuppressive agents on PHA- and CD3-stimulated human lymphocyte proliferation in vitro.
Jiang H; Suguo H; Takahara S; Takano Y; Li D; Kameoka H; Moutabarrik A; Kokado Y; Ishibashi M; Okuyama A
Transplant Proc; 1991 Dec; 23(6):2933-6. PubMed ID: 1721317
[No Abstract] [Full Text] [Related]
12. Anti-CD2 monoclonal antibodies synergize with anti-CD3 to prolong allograft survival and decrease cytokine production.
Chavin KD; Qin L; Lin J; Kaplan AJ; Bromberg JS
Transplant Proc; 1993 Feb; 25(1 Pt 1):823-4. PubMed ID: 8094913
[No Abstract] [Full Text] [Related]
13. HLA typing using IL-2 activated T lymphocytes: usefulness in pediatric candidates for allogeneic bone marrow transplantation.
Kubo K; Tachino J; Ichikawa S; Hamamoto K; Ueda K
Bone Marrow Transplant; 1991 Sep; 8(3):185-90. PubMed ID: 1720338
[TBL] [Abstract][Full Text] [Related]
14. Myoinositol may be a factor in uremic immune deficiency.
Bartnicki P; Zbróg Z; Baj Z; Tchórzewski H; Luciak M
Clin Nephrol; 1997 Mar; 47(3):197-201. PubMed ID: 9105768
[TBL] [Abstract][Full Text] [Related]
15. Tyrosine phosphorylation of interleukin 2 receptor-related proteins in phytohemagglutinin-activated human lymphocytes.
Ogawa R; Sugamura K; Watanabe Y
Biochem Biophys Res Commun; 1987 Apr; 144(1):160-5. PubMed ID: 3034242
[TBL] [Abstract][Full Text] [Related]
16. CD3-/HLA-DR+, CD3+/HLA-DR+ cell levels and PHA stimulation of lymphocytes obtained from women with recurrent spontaneous abortions and subjected to partner's lymphocyte immunization.
Wilczyński J; Sułowska Z; Malinowski A; Zeman K; Szpakowski M; Tchórzewski H; Podciechowski L
Arch Immunol Ther Exp (Warsz); 1997; 45(4):289-94. PubMed ID: 9523003
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of antibodies to CD3 surface antigen and phytohemagglutinin-mediated T cellular responses by inhibiting Ca2+/phospholipid-dependent protein kinase activity with the aid of 1-(5-isoquinolinylsulfonyl)-2-methylpiperazine dihydrochloride.
Nel AE; Schabort I; Rheeder A; Bouic P; Wooten MW
J Immunol; 1987 Oct; 139(7):2230-6. PubMed ID: 2821109
[TBL] [Abstract][Full Text] [Related]
18. Interferon-gamma regulates the T cell response to precursor nevi and biologically early melanoma.
Guerry D; Alexander MA; Elder DE; Herlyn MF
J Immunol; 1987 Jul; 139(1):305-12. PubMed ID: 3108402
[TBL] [Abstract][Full Text] [Related]
19. Microcytotoxic HLA typing of cells directly isolated from blood by means of antibody-coated microspheres.
Vartdal F; Bratlie A; Gaudernack G; Funderud S; Lea T; Thorsby E
Transplant Proc; 1987 Feb; 19(1 Pt 1):655-7. PubMed ID: 3152705
[No Abstract] [Full Text] [Related]
20. The required interaction between monocytes and peripheral blood T lymphocytes (T-PBL) upon activation via CD2 or CD3. Role of HLA class I molecules from accessory cells and the differential response of T-PBL subsets.
Huet S; Boumsell L; Dausset J; Degos L; Bernard A
Eur J Immunol; 1988 Aug; 18(8):1187-94. PubMed ID: 2901355
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
